We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Denali Therapeutics
DNLI
$3.67B
| $11.4M | 0.01% |
787,029
-618,221
| -44% | -$8.88M |
|
852
CALL
iShares Biotechnology ETF
IBB
$9.31B
| $11.4M | 0.01% |
78,700
+73,900
| +1,540% | +$10.1M |
|
853
Lumentum
LITE
$59.4B
| $11.4M | 0.01% |
69,798
+52,793
| +310% | +$6.58M |
|
854
Intapp
INTA
$2.12B
| $11.3M | 0.01% |
276,063
+262,641
| +1,957% | +$11.4M |
|
855
Carter's
CRI
$1.43B
| $11.3M | 0.01% |
399,992
-542,739
| -58% | -$15.6M |
|
856
Hercules Capital
HTGC
$2.94B
| $11.2M | 0.01% |
+592,242
| New | +$11.4M |
|
857
CALL
KraneShares CSI China Internet ETF
KWEB
$5.2B
| $11.2M | 0.01% |
266,400
-42,200
| -14% | -$1.58M |
|
|
SFIX
858
Stitch Fix
SFIX
$478M
| $11.2M | 0.01% |
2,572,372
+562,338
| +28% | +$2.78M |
|
|
HAPN
859
Happen Inc
HAPN
$2.08B
| $11.2M | 0.01% |
735,821
+680,589
| +1,232% | +$10.3M |
|
860
GE Vernova
GEV
$270B
| $11.1M | 0.01% |
18,089
+13,389
| +285% | +$8.11M |
|
861
HNI Corp
HNI
$3B
| $11.1M | 0.01% |
+237,371
| New | +$11.2M |
|
862
XP
XP
$8.62B
| $11.1M | 0.01% |
591,826
-717,364
| -55% | -$12.9M |
|
863
iShares China Large-Cap ETF
FXI
$4.31B
| $11.1M | 0.01% |
269,777
-309,864
| -53% | -$12M |
|
864
Blackbaud
BLKB
$1.5B
| $11.1M | 0.01% |
172,576
+139,326
| +419% | +$9.13M |
|
865
Ero Copper
ERO
$2.71B
| $11M | 0.01% |
543,723
-65,898
| -11% | -$1M |
|
866
Encompass Health
EHC
$11.2B
| $11M | 0.01% |
86,220
-196,902
| -70% | -$23.4M |
|
867
Cerence
CRNC
$382M
| $10.9M | 0.01% |
878,491
-234,722
| -21% | -$2.4M |
|
868
Mettler-Toledo International
MTD
$26.8B
| $10.9M | 0.01% |
8,895
-50,925
| -85% | -$63.8M |
|
869
Kohl's
KSS
$2.03B
| $10.9M | 0.01% |
710,046
+666,845
| +1,544% | +$8.89M |
|
870
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| $10.9M | 0.01% |
138,500
+85,400
| +161% | +$6.9M |
|
871
Hertz
HTZ
$572M
| $10.9M | 0.01% |
1,595,988
-167,815
| -10% | -$1.08M |
|
872
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
| $10.8M | 0.01% |
+97,800
| New | +$10.7M |
|
873
GCM Grosvenor
GCMG
$737M
| $10.8M | 0.01% |
897,475
-109,066
| -11% | -$1.35M |
|
|
874
CALL
Microsoft
MSFT
$2.84T
| $10.8M | 0.01% |
20,900
+20,300
| +3,383% | +$10.4M |
|
875
Amcor
AMCR
$20.6B
| $10.8M | 0.01% |
264,335
-2,121,951
| -89% | -$95.1M |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.